Table 1 Association between IBD therapy, seroconversion and hospitalization.

From: Unravelling the cellular response to the SARS-COV-2 vaccine in inflammatory bowel disease patients on biologic drugs

Treatment

Seroconversion

p-value*

Hospitalization

p-value*

Anti-TNF

 < 0.001

**aOR0.25 95%CI (0.10–0.61), p = 0.002

0.316

Non-anti-TNF biologic drug

0.350

1.000

Immunosuppressant + anti-TNF

0.067

0.421

Immunosuppressant + non-anti-TNF biologic drug

0.602

1.000

Immunosuppressant

0.561

1.000

Steroids

0.627

0.201

  1. Treatments were compared using patients receiving no treatment and/or5-ASA alone as the reference group.
  2. ASA 5-aminosalicylic acid, TNF tumor necrosis factor.
  3. *Univariable analysis.
  4. **Multivariable analysis.
  5. Significant values are in bold.
Back to article page